Microglia: proliferation and activation driven by the P2X7 receptor.
Mastura Monif1, Geoffrey Burnstock, David A Williams
1Department of Physiology, The University of Melbourne, Melbourne, Victoria, Australia.
Summary
The purinergic P2X7 receptor (P2X7R) drives microglial activation, a key process in neuroinflammation and neurodegeneration seen in Alzheimer's and Parkinson's diseases.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Microglial activation is implicated in various neurodegenerative diseases, including Alzheimer's and Parkinson's.
- The precise molecular mechanisms driving microglial activation remain largely unelucidated.
- Elevated purinergic P2X7 receptor (P2X7R) expression is observed in brain pathologies featuring activated microglia.
Purpose of the Study:
- To review the relationship between P2X7R expression and microglial activation.
- To explore the role of P2X7R in microgliosis and its contribution to neuroinflammation.
Main Methods:
- Literature review focusing on studies investigating P2X7R and microglial activation.
- Analysis of the role of P2X7R in cellular processes like activation and proliferation.
Main Results:
- P2X7R expression is upregulated in conditions associated with microglial activation.
- P2X7R signaling is identified as a critical factor in initiating and sustaining microglial activation.
Conclusions:
- The purinergic P2X7 receptor is a key mediator of microgliosis.
- Targeting P2X7R may offer a therapeutic strategy to mitigate neuroinflammation and neurodegeneration in various brain disorders.
